Glanbia posts ‘solid’ first half results
Glanbia posts solid HY 2025 growth in Health & Nutrition and Dairy, upgrading full-year earnings guidance
18 August 2025
Glanbia has recently reported solid momentum in the first half of 2025, driven by double-digit growth in its Health & Nutrition (H&N) and Dairy Nutrition (DN) divisions, alongside consecutive improvement in Performance Nutrition (PN).
Group revenues rose 6% to $1.93 billion, with volume growth of 0.9%, while adjusted EPS was 63.03 cents, down 7.5% year-on-year.
Surges
Health & Nutrition revenues surged 18%, supported by acquisitions and volume gains, while Dairy Nutrition delivered 14% growth.
Performance Nutrition declined 3.8%, reflecting elevated whey costs, but Optimum Nutrition achieved 2% revenue growth in Q2, signalling recovery.
The Group announced the acquisition of Brazil-based Sweetmix, strengthening its Latin American footprint, while also confirming the planned sale of Body & Fit. Shareholder returns included a 10% dividend increase and €62.8 million in buybacks.
Looking ahead, Glanbia has upgraded full-year adjusted EPS guidance to 130–133 cents, citing improved revenue momentum and margin progression.
Commenting today Hugh McGuire, chief executive officer, said: “Today’s (13 August) results reflect a first half of significant execution and progress as we generated 6% revenue growth in the period, underpinned by strong growth in H&N and DN and a sequential improvement in PN through the period as the Group navigated significant macroeconomic volatility.
“First half results were driven by volume growth, earnings and margin progression in H&N and DN, reflecting strong customer demand.
“This was offset by anticipated reduced performance in PN primarily as a result of elevated whey costs during the period.
“In the second quarter, we were pleased to see volume and price growth in our flagship brand, Optimum Nutrition.
“Within our H&N division, we have today announced the acquisition of Sweetmix, a Brazil-based nutritional premix and ingredients solutions business, facilitating continued growth in the Latin America region.
“We delivered strong operating returns and cash conversion and continue to have a disciplined approach to capital allocation, with a 10% increase in the interim dividend and €62.8 million returned to shareholders via share buyback programmes during the period.
“We are today upgrading our full year adjusted EPS guidance to 130 to 133 $cent5 as a result of increased revenue momentum in PN and improved margins in H&N. The category trends remain positive, and we expect to see continued improvement in volumes across PN in the second half of the year with continued momentum in H&N and DN.”
Read more: Glanbia delivers ‘resilient performance’ during Q1
© 2025, ShelfLife by Ryan Brennan



Print



Followers 0
Fans 0
Followers